Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 237

1.

Unmet information needs of patients with melanoma in Germany.

Brütting J, Bergmann M, Garzarolli M, Rauschenberg R, Weber C, Berking C, Tilgen W, Schadendorf D, Meier F; on behalf of the NVKH supporting group.

Melanoma Res. 2018 May 21. doi: 10.1097/CMR.0000000000000464. [Epub ahead of print]

PMID:
29787460
2.

Quality, Readability, and Understandability of German Booklets Addressing Melanoma Patients.

Brütting J, Reinhardt L, Bergmann M, Schadendorf D, Weber C, Tilgen W, Berking C, Meier F; NVKH.

J Cancer Educ. 2018 May 7. doi: 10.1007/s13187-018-1369-x. [Epub ahead of print]

PMID:
29736794
3.

[Information services for melanoma patients and awareness among those affected].

Brütting J, Bergmann M, Weber C, Berking C, Tilgen W, Schadendorf D, Meier F.

Hautarzt. 2018 Apr;69(4):335-339. doi: 10.1007/s00105-018-4130-9. German.

PMID:
29396641
4.

Intermittent High-Dose Intravenous Interferon Alfa-2b for Adjuvant Treatment of Stage III Melanoma: Final Analysis of a Randomized Phase III Dermatologic Cooperative Oncology Group Trial.

Mohr P, Hauschild A, Trefzer U, Enk A, Tilgen W, Loquai C, Gogas H, Haalck T, Koller J, Dummer R, Gutzmer R, Brockmeyer N, Hölzle E, Sunderkötter C, Mauch C, Stein A, Schneider LA, Podda M, Göppner D, Schadendorf D, Weichenthal M.

J Clin Oncol. 2015 Dec 1;33(34):4077-84. doi: 10.1200/JCO.2014.59.6932. Epub 2015 Oct 26.

PMID:
26503196
5.

Same Site Recurrence is More Frequent After Endovenous Laser Ablation Compared with High Ligation and Stripping of the Great Saphenous Vein: 5 year Results of a Randomized Clinical Trial (RELACS Study).

Rass K, Frings N, Glowacki P, Gräber S, Tilgen W, Vogt T.

Eur J Vasc Endovasc Surg. 2015 Nov;50(5):648-56. doi: 10.1016/j.ejvs.2015.07.020. Epub 2015 Aug 28.

6.

Reciprocal responses of fibroblasts and melanocytes to α-MSH depending on MC1R polymorphisms.

Stanisz H, Seifert M, Tilgen W, Vogt T, Rass K.

Dermatoendocrinol. 2011 Oct;3(4):259-65. doi: 10.4161/derm.3.4.17454. Epub 2011 Oct 1.

7.

Association of genetic variants of the vitamin D receptor (VDR) with cutaneous squamous cell carcinomas (SCC) and basal cell carcinomas (BCC): a pilot study in a German population.

Köstner K, Denzer N, Koreng M, Reichrath S, Gräber S, Klein R, Tilgen W, Vogt T, Reichrath J.

Anticancer Res. 2012 Jan;32(1):327-33.

PMID:
22213323
8.

Prospective evaluation of supportive care with or without CVD chemotherapy as a second-line treatment in advanced melanoma by patient's choice: a multicentre Dermatologic Cooperative Oncology Group trial.

Hofmann MA, Hauschild A, Mohr P, Garbe C, Weichenthal M, Trefzer U, Drecoll U, Tilgen W, Schadendorf D, Kaatz M, Ulrich J.

Melanoma Res. 2011 Dec;21(6):516-23. doi: 10.1097/CMR.0b013e3283485ff0.

PMID:
22076216
9.

Comparable effectiveness of endovenous laser ablation and high ligation with stripping of the great saphenous vein: two-year results of a randomized clinical trial (RELACS study).

Rass K, Frings N, Glowacki P, Hamsch C, Gräber S, Vogt T, Tilgen W.

Arch Dermatol. 2012 Jan;148(1):49-58. doi: 10.1001/archdermatol.2011.272. Epub 2011 Sep 19.

PMID:
21931012
10.

Construction and evaluation of a multidimensional score to assess varicose vein severity - the Homburg Varicose Vein Severity Score (HVVSS).

Rass K, Daschzeren M, Gräber S, Vogt T, Tilgen W, Frings N.

Eur J Dermatol. 2011 Jul-Aug;21(4):577-84. doi: 10.1684/ejd.2011.1368.

PMID:
21680286
11.

Health-related quality of life before and during adjuvant interferon-α treatment for patients with malignant melanoma (DeCOG-trial).

Ziefle S, Egberts F, Heinze S, Volkenandt M, Schmid-Wendtner M, Tilgen W, Linse R, Boettjer J, Vogt T, Spieth K, Eigentler T, Brockmeyer NH, Heinz A, Hauschild A, Schaefer M.

J Immunother. 2011 May;34(4):403-8. doi: 10.1097/CJI.0b013e31821b7a4b.

PMID:
21499123
12.

Genetic variations in the genes encoding receptor activator nuclear factor κ B (RANK), receptor activator nuclear factor κ B ligand (RANKL) and osteoprotegerin (OPG) in patients with psoriasis and psoriatic arthritis: a case-control study.

Assmann G, Pfoehler C, Simon P, Pfreundschuh M, Tilgen W, Wieczorek S.

J Dermatol. 2011 Jun;38(6):519-23. doi: 10.1111/j.1346-8138.2010.01055.x. Epub 2010 Nov 2.

PMID:
21352301
13.

Caterpillar dermatitis revisited: lepidopterism after contact with oak processionary caterpillar.

Müller CS, Tilgen W, Pföhler C.

BMJ Case Rep. 2011 Apr 19;2011. pii: bcr0320113967. doi: 10.1136/bcr.03.2011.3967.

14.

Venoarterial flow index steadily improves after endovenous laser treatment of the great saphenous vein.

Rass K, Pasquini C, Hamsch C, Gräber S, Frings N, Tilgen W.

Dermatol Surg. 2010 Nov;36(11):1691-9. doi: 10.1111/j.1524-4725.2010.01720.x.

PMID:
20961350
15.

Primary manifestation of erythema gyratum repens as a transient erythroderma in a patient with bronchial carcinoma.

Müller CS, Lorenz MT, Tilgen W, Rass K.

Int J Dermatol. 2010 Jun;49(6):676-8. doi: 10.1111/j.1365-4632.2009.04387.x. No abstract available.

PMID:
20618474
16.
18.

Leucocytoclastic vasculitis associated with acquired reactive perforating collagenosis: A diagnostic mimicry.

Müller CS, Tilgen W, Rass K.

Dermatoendocrinol. 2009 Jul;1(4):229-31. No abstract available.

19.

Recurring mixed-type neurothekeoma of the face.

Müller CS, Tilgen W, Kutzner H, Pföhler C.

Dermatoendocrinol. 2009 Jul;1(4):220-2.

20.

Cutaneous and systemic metastasis of a testicular choriocarcinoma.

Müller CS, Tilgen W, Pföhler C, Graf N.

Am J Dermatopathol. 2010 Jul;32(5):521-2. doi: 10.1097/DAD.0b013e3181c0e127. No abstract available.

PMID:
20571348

Supplemental Content

Loading ...
Support Center